Global Optic Nerve Glioma Market Size, Status and Forecast 2019-2025

Published On: Jun 2019

Format: PDF

Publisher: QY Research

Pages: 92

Report ID: 1349

An optic nerve glioma is a type of brain tumor. There are multiple kinds of brain tumors. Typically, each type of tumor is named after the kinds of cells it affects. Most optic nerve gliomas are considered low-grade and don’t grow as quickly as other types of brain tumors. They are found in the optic chiasm, where the left and right optic nerves cross. They are also referred to as optic glioma or juvenile pilocytic astrocytoma. Optic nerve glioma is a rare kind of cancer that’s typically slow growing and found in children. It is rarely found in individuals over the age of 20. It has also been associated with the genetic disorder neurofibromatosis type 1, or NF1.
Treatment for these cancers is best done by a multidisciplinary treatment team. Surgery and radiation therapy are two possible ways of treating optic nerve glioma. Surgery may be performed if doctors believe they can use it to completely remove the tumor. Alternately, if the tumor is not completely removable, surgeons may remove parts of it to help relieve pressure in the skull. Radiation therapy can be done before surgery to shrink the tumor before doctors it. Alternately, it may be done after surgery to kill any remaining cancer cells. Radiation therapy involves using a machine to aim high-energy rays at the site of the tumor. Chemotherapy uses medications to kill cancer cells. This is particularly useful if the cancer has spread to other parts of the brain. Corticosteroids may be administered to reduce swelling in the skull.
In 2018, the global Optic Nerve Glioma market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Optic Nerve Glioma status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Optic Nerve Glioma development in United States, Europe and China.

The key players covered in this study
Biocompare
Bio-Rad Laboratories
Miltenyi Biotec
BioLegend
Becton, Dickinson And Company
Beckman Coulter
Merck
ImmunoReagents
Thermo Fisher Scientific

Market segment by Type, the product can be split into
Malignant Optic Nerve Glioma
Benign Optic Nerve Glioma

Market segment by Application, split into
Hospitals & Clinics
Diagnostic Centers

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Optic Nerve Glioma status, future forecast, growth opportunity, key market and key players.
To present the Optic Nerve Glioma development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Optic Nerve Glioma are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Optic Nerve Glioma Market Size Growth Rate by Type (2014-2025)
1.4.2 Malignant Optic Nerve Glioma
1.4.3 Benign Optic Nerve Glioma
1.5 Market by Application
1.5.1 Global Optic Nerve Glioma Market Share by Application (2014-2025)
1.5.2 Hospitals & Clinics
1.5.3 Diagnostic Centers
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Optic Nerve Glioma Market Size
2.2 Optic Nerve Glioma Growth Trends by Regions
2.2.1 Optic Nerve Glioma Market Size by Regions (2014-2025)
2.2.2 Optic Nerve Glioma Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Optic Nerve Glioma Market Size by Manufacturers
3.1.1 Global Optic Nerve Glioma Revenue by Manufacturers (2014-2019)
3.1.2 Global Optic Nerve Glioma Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Optic Nerve Glioma Market Concentration Ratio (CR5 and HHI)
3.2 Optic Nerve Glioma Key Players Head office and Area Served
3.3 Key Players Optic Nerve Glioma Product/Solution/Service
3.4 Date of Enter into Optic Nerve Glioma Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Optic Nerve Glioma Market Size by Type (2014-2019)
4.2 Global Optic Nerve Glioma Market Size by Application (2014-2019)

5 United States
5.1 United States Optic Nerve Glioma Market Size (2014-2019)
5.2 Optic Nerve Glioma Key Players in United States
5.3 United States Optic Nerve Glioma Market Size by Type
5.4 United States Optic Nerve Glioma Market Size by Application

6 Europe
6.1 Europe Optic Nerve Glioma Market Size (2014-2019)
6.2 Optic Nerve Glioma Key Players in Europe
6.3 Europe Optic Nerve Glioma Market Size by Type
6.4 Europe Optic Nerve Glioma Market Size by Application

7 China
7.1 China Optic Nerve Glioma Market Size (2014-2019)
7.2 Optic Nerve Glioma Key Players in China
7.3 China Optic Nerve Glioma Market Size by Type
7.4 China Optic Nerve Glioma Market Size by Application

8 Japan
8.1 Japan Optic Nerve Glioma Market Size (2014-2019)
8.2 Optic Nerve Glioma Key Players in Japan
8.3 Japan Optic Nerve Glioma Market Size by Type
8.4 Japan Optic Nerve Glioma Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Optic Nerve Glioma Market Size (2014-2019)
9.2 Optic Nerve Glioma Key Players in Southeast Asia
9.3 Southeast Asia Optic Nerve Glioma Market Size by Type
9.4 Southeast Asia Optic Nerve Glioma Market Size by Application

10 India
10.1 India Optic Nerve Glioma Market Size (2014-2019)
10.2 Optic Nerve Glioma Key Players in India
10.3 India Optic Nerve Glioma Market Size by Type
10.4 India Optic Nerve Glioma Market Size by Application

11 Central & South America
11.1 Central & South America Optic Nerve Glioma Market Size (2014-2019)
11.2 Optic Nerve Glioma Key Players in Central & South America
11.3 Central & South America Optic Nerve Glioma Market Size by Type
11.4 Central & South America Optic Nerve Glioma Market Size by Application

12 International Players Profiles
12.1 Biocompare
12.1.1 Biocompare Company Details
12.1.2 Company Description and Business Overview
12.1.3 Optic Nerve Glioma Introduction
12.1.4 Biocompare Revenue in Optic Nerve Glioma Business (2014-2019)
12.1.5 Biocompare Recent Development
12.2 Bio-Rad Laboratories
12.2.1 Bio-Rad Laboratories Company Details
12.2.2 Company Description and Business Overview
12.2.3 Optic Nerve Glioma Introduction
12.2.4 Bio-Rad Laboratories Revenue in Optic Nerve Glioma Business (2014-2019)
12.2.5 Bio-Rad Laboratories Recent Development
12.3 Miltenyi Biotec
12.3.1 Miltenyi Biotec Company Details
12.3.2 Company Description and Business Overview
12.3.3 Optic Nerve Glioma Introduction
12.3.4 Miltenyi Biotec Revenue in Optic Nerve Glioma Business (2014-2019)
12.3.5 Miltenyi Biotec Recent Development
12.4 BioLegend
12.4.1 BioLegend Company Details
12.4.2 Company Description and Business Overview
12.4.3 Optic Nerve Glioma Introduction
12.4.4 BioLegend Revenue in Optic Nerve Glioma Business (2014-2019)
12.4.5 BioLegend Recent Development
12.5 Becton, Dickinson And Company
12.5.1 Becton, Dickinson And Company Company Details
12.5.2 Company Description and Business Overview
12.5.3 Optic Nerve Glioma Introduction
12.5.4 Becton, Dickinson And Company Revenue in Optic Nerve Glioma Business (2014-2019)
12.5.5 Becton, Dickinson And Company Recent Development
12.6 Beckman Coulter
12.6.1 Beckman Coulter Company Details
12.6.2 Company Description and Business Overview
12.6.3 Optic Nerve Glioma Introduction
12.6.4 Beckman Coulter Revenue in Optic Nerve Glioma Business (2014-2019)
12.6.5 Beckman Coulter Recent Development
12.7 Merck
12.7.1 Merck Company Details
12.7.2 Company Description and Business Overview
12.7.3 Optic Nerve Glioma Introduction
12.7.4 Merck Revenue in Optic Nerve Glioma Business (2014-2019)
12.7.5 Merck Recent Development
12.8 ImmunoReagents
12.8.1 ImmunoReagents Company Details
12.8.2 Company Description and Business Overview
12.8.3 Optic Nerve Glioma Introduction
12.8.4 ImmunoReagents Revenue in Optic Nerve Glioma Business (2014-2019)
12.8.5 ImmunoReagents Recent Development
12.9 Thermo Fisher Scientific
12.9.1 Thermo Fisher Scientific Company Details
12.9.2 Company Description and Business Overview
12.9.3 Optic Nerve Glioma Introduction
12.9.4 Thermo Fisher Scientific Revenue in Optic Nerve Glioma Business (2014-2019)
12.9.5 Thermo Fisher Scientific Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details